Towards better treatments: working with pharma

How a new type of partnership is bringing the voice of those affected by Parkinson’s into pharmaceutical research.

Claire Nolan
Feb 12, 2018 · 5 min read
Image for post
Image for post

“We all want a drug that will slow, stop or even reverse Parkinson’s, but progress seems so slow. Clinical trials need to be speeded up; more money needs to be invested in drug development… co-ordination of developments worldwide must be improved… If this is already happening, tell us about it… we all need the reassurance that a major co-ordination effort is in place…”

— David, Research Support Network member

Image for post
Image for post
Image for post
Image for post
Image for post
Image for post
Image for post
Image for post

Parkinson’s UK

Get the latest research news, discover more about…

Claire Nolan

Written by

Parkinson’s UK

Get the latest research news, discover more about Parkinson’s and read about how others are getting involved. For information and support, visit www.parkinsons.org.uk

Claire Nolan

Written by

Parkinson’s UK

Get the latest research news, discover more about Parkinson’s and read about how others are getting involved. For information and support, visit www.parkinsons.org.uk

Welcome to a place where words matter. On Medium, smart voices and original ideas take center stage - with no ads in sight. Watch

Follow all the topics you care about, and we’ll deliver the best stories for you to your homepage and inbox. Explore

Get unlimited access to the best stories on Medium — and support writers while you’re at it. Just $5/month. Upgrade

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store